Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 47 Squamous Cell Carcinoma of Head and Neck 19 Carcinoma, Non-Small-Cell Lung 15 Neoplasms 12 Head and Neck Neoplasms 9 Neoplasm Metastasis 8 Lung Neoplasms 8 Carcinoma, Squamous Cell 7 Pancreatic Neoplasms 6 Colonic Neoplasms 6 Solid Tumors 5 Rectal Neoplasms 4 Mouth Neoplasms 3 Laryngeal Neoplasms 3 Hypopharyngeal Neoplasms 3 Gastrointestinal Neoplasms 3 Colorectal Cancer Metastatic 3 Carcinoma 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Recurrence 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 Melanoma 2 Locally Recurrent Rectal Cancer 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Pancreatic Ductal 2 Advanced Solid Tumor 2

Interventions

Injections 16 pembrolizumab 6 Bevacizumab 6 Paclitaxel 4 Leucovorin 4 Fluorouracil 4 Carboplatin 4 fludarabine 3 Pemetrexed 3 Oxaliplatin 3 Capecitabine 3 toripalimab 2 sotorasib 2 Immune Checkpoint Inhibitors 2 Fulvestrant 2 Drug Therapy 2 Docetaxel 2 Cyclophosphamide 2 Cisplatin 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1 trifluridine tipiracil drug combination 1 trametinib 1 tislelizumab 1 sacituzumab govitecan 1 palbociclib 1 osimertinib 1 olaparib 1 lazertinib 1 fluzoparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Advanced Solid Tumors × Cetuximab × Clear all

NCT05067283 2026-05-26

KANDLELIT-001

Merck Sharp & Dohme LLC

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡